Cargando…
Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537]
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417583/ https://www.ncbi.nlm.nih.gov/pubmed/33814256 http://dx.doi.org/10.1016/j.ejps.2021.105827 |
_version_ | 1783748406312697856 |
---|---|
author | Mirza, Muhammad Usman Saadabadi, Atefeh Vanmeert, Michiel Salo-Ahen, Outi M.H. Abdullah, Iskandar Claes, Sandra De Jonghe, Steven Schols, Dominique Ahmad, Sarfraz Froeyen, Matheus |
author_facet | Mirza, Muhammad Usman Saadabadi, Atefeh Vanmeert, Michiel Salo-Ahen, Outi M.H. Abdullah, Iskandar Claes, Sandra De Jonghe, Steven Schols, Dominique Ahmad, Sarfraz Froeyen, Matheus |
author_sort | Mirza, Muhammad Usman |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8417583 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84175832021-09-07 Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537] Mirza, Muhammad Usman Saadabadi, Atefeh Vanmeert, Michiel Salo-Ahen, Outi M.H. Abdullah, Iskandar Claes, Sandra De Jonghe, Steven Schols, Dominique Ahmad, Sarfraz Froeyen, Matheus Eur J Pharm Sci Corrigendum Elsevier B.V. 2021-07-01 2021-04-01 /pmc/articles/PMC8417583/ /pubmed/33814256 http://dx.doi.org/10.1016/j.ejps.2021.105827 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Corrigendum Mirza, Muhammad Usman Saadabadi, Atefeh Vanmeert, Michiel Salo-Ahen, Outi M.H. Abdullah, Iskandar Claes, Sandra De Jonghe, Steven Schols, Dominique Ahmad, Sarfraz Froeyen, Matheus Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537] |
title | Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537] |
title_full | Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537] |
title_fullStr | Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537] |
title_full_unstemmed | Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537] |
title_short | Corrigendum to ‘Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach’ [European Journal of Pharmaceutical Sciences 155 (2020) 105537] |
title_sort | corrigendum to ‘discovery of hiv entry inhibitors via a hybrid cxcr4 and ccr5 receptor pharmacophore-based virtual screening approach’ [european journal of pharmaceutical sciences 155 (2020) 105537] |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417583/ https://www.ncbi.nlm.nih.gov/pubmed/33814256 http://dx.doi.org/10.1016/j.ejps.2021.105827 |
work_keys_str_mv | AT mirzamuhammadusman corrigendumtodiscoveryofhiventryinhibitorsviaahybridcxcr4andccr5receptorpharmacophorebasedvirtualscreeningapproacheuropeanjournalofpharmaceuticalsciences1552020105537 AT saadabadiatefeh corrigendumtodiscoveryofhiventryinhibitorsviaahybridcxcr4andccr5receptorpharmacophorebasedvirtualscreeningapproacheuropeanjournalofpharmaceuticalsciences1552020105537 AT vanmeertmichiel corrigendumtodiscoveryofhiventryinhibitorsviaahybridcxcr4andccr5receptorpharmacophorebasedvirtualscreeningapproacheuropeanjournalofpharmaceuticalsciences1552020105537 AT saloahenoutimh corrigendumtodiscoveryofhiventryinhibitorsviaahybridcxcr4andccr5receptorpharmacophorebasedvirtualscreeningapproacheuropeanjournalofpharmaceuticalsciences1552020105537 AT abdullahiskandar corrigendumtodiscoveryofhiventryinhibitorsviaahybridcxcr4andccr5receptorpharmacophorebasedvirtualscreeningapproacheuropeanjournalofpharmaceuticalsciences1552020105537 AT claessandra corrigendumtodiscoveryofhiventryinhibitorsviaahybridcxcr4andccr5receptorpharmacophorebasedvirtualscreeningapproacheuropeanjournalofpharmaceuticalsciences1552020105537 AT dejonghesteven corrigendumtodiscoveryofhiventryinhibitorsviaahybridcxcr4andccr5receptorpharmacophorebasedvirtualscreeningapproacheuropeanjournalofpharmaceuticalsciences1552020105537 AT scholsdominique corrigendumtodiscoveryofhiventryinhibitorsviaahybridcxcr4andccr5receptorpharmacophorebasedvirtualscreeningapproacheuropeanjournalofpharmaceuticalsciences1552020105537 AT ahmadsarfraz corrigendumtodiscoveryofhiventryinhibitorsviaahybridcxcr4andccr5receptorpharmacophorebasedvirtualscreeningapproacheuropeanjournalofpharmaceuticalsciences1552020105537 AT froeyenmatheus corrigendumtodiscoveryofhiventryinhibitorsviaahybridcxcr4andccr5receptorpharmacophorebasedvirtualscreeningapproacheuropeanjournalofpharmaceuticalsciences1552020105537 |